Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (19)

2022

  1. Evaluation of Macular Thickness Changes after Uncomplicated Phacoemulsification Surgery in Healthy Subjects and Diabetic Patients without Retinopathy by Spectral Domain OCT

    Diagnostics, Vol. 12, Núm. 12

2021

  1. Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons

    Frontiers in Pharmacology, Vol. 12

  2. The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival

    Frontiers in Pharmacology, Vol. 12

2020

  1. Comparative lipidomic analysis of mammalian retinal ganglion cells and Müller glia in situ and in vitro using High-Resolution Imaging Mass Spectrometry

    Scientific Reports, Vol. 10, Núm. 1

  2. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?

    Lupus, Vol. 29, Núm. 7, pp. 671-675

2018

  1. The retina of osteopontin deficient mice in aging

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 213-221

2016

  1. Evaluation of 10 AMD Associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia six years outcome

    Retina, Vol. 35, Núm. 12, pp. 2450-2456

2014

  1. Do nutritional supplements have a role in age macular degeneration prevention?

    Journal of Ophthalmology, Vol. 2014

2013

  1. Lutein and Diabetic Cataracts

    Bioactive Food as Dietary Interventions for Diabetes (Elsevier Inc.), pp. 275-289

  2. Spectral-domain optical coherence tomography study of macular structure as prognostic and determining factor for macular hole surgery outcome

    Retina, Vol. 33, Núm. 6, pp. 1117-1122

2012

  1. Lutein and Diabetic Cataracts

    Bioactive Food as Dietary Interventions for Diabetes: Bioactive Foods in Chronic Disease States (Elsevier), pp. 275-289

  2. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization

    Acta Ophthalmologica

2010

  1. Comparative effects of six intraocular vital dyes on retinal pigment epithelial cell

    Investigative Ophthalmology and Visual Science, Vol. 51, Núm. 11, pp. 6018-6029

  2. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization

    Retina, Vol. 30, Núm. 10, pp. 1609-1615

2009

  1. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats

    Current Eye Research, Vol. 34, Núm. 11, pp. 928-938

2007

  1. Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration

    Neurochemical Research, Vol. 32, Núm. 7, pp. 1156-1162

2006

  1. Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization

    Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748

2005

  1. The pig eye as a novel model of glaucoma

    Experimental Eye Research, Vol. 81, Núm. 5, pp. 561-569